Related Experiment Video
Updated: Jun 15, 2025

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
Deep vein thrombosis in patients with stroke or transient ischemic attack presenting with patent foramen ovale: a
Charlotte Huber1, Stephan Stöbe2, Andreas Hagendorff2
1Department of Neurology, University of Leipzig, Liebigstr. 20, 04103, Leipzig, Germany.
Insights
Deep vein thrombosis (DVT) occurs in a significant number of stroke patients with a patent foramen ovale (PFO). The Wells score can help identify patients who need further screening for DVT.
Area of Science:
- Cardiology
- Neurology
- Vascular Medicine
Background:
- Patent foramen ovale (PFO) is linked to paradoxical embolism causing cerebral ischemia.
- Deep vein thrombosis (DVT) is a potential source of embolism in PFO patients, but screening rates vary.
- Lack of clear guidelines necessitates characterizing DVT prevalence in stroke/TIA patients with PFO.
Purpose of the Study:
- To determine the rate of DVT in patients with stroke or transient ischemic attack (TIA) and PFO.
- To identify clinical, demographic, and laboratory parameters associated with DVT in this population.
- To evaluate the utility of risk scores in predicting DVT.
Main Methods:
- Retrospective analysis of medical records for patients with stroke/TIA and PFO.
- DVT diagnosis via lower limb compression ultrasonography.
- Comparison of demographic, clinical, laboratory data, RoPE, and Wells scores between DVT+ and DVT- groups.
Main Results:
- 339 patients (61.2±15.4 years, 61.1% male) with stroke/TIA and PFO were identified.
- DVT was detected in 7.8% (17/217) of patients undergoing ultrasonography.
- DVT was associated with prior DVT, cancer, immobilization, calf pain/swelling, and elevated D-dimer. The Wells score was a significant predictor (OR 35.46).
Conclusions:
- DVT is present in a relevant proportion of patients with cerebral ischemia and PFO.
- Screening for DVT should be considered in the diagnostic workup of these patients.
- The Wells score may effectively guide the need for compression ultrasonography.
Objective:
Deep vein thrombosis (DVT) is discussed as a source of embolism for cerebral ischemia in the presence of patent foramen ovale (PFO). However, previous studies reported varying rates of DVT in stroke patients, and recommendations for screening are lacking. This study aimed to characterize patients with stroke or transient ischemic attack (TIA) and concomitant PFO and explore the rate of DVT and associated parameters.
Methods:
Medical records were screened for patients with stroke or TIA and echocardiographic evidence of PFO. Concomitant DVT was identified according to compression ultrasonography of the lower limbs. A variety of demographic, clinical, and laboratory parameters, the RoPE and Wells scores were compared between patients with and without DVT.
Results:
Three-hundred-thirty-nine patients (mean age 61.2 ± 15.4 years, 61.1% male) with stroke or TIA and PFO, treated between 01/2015 and 12/2020, were identified. Stroke and TIA patients did not differ for demographic and vascular risk factors. DVT was found in 17 cases out of 217 (7.8%) with compression ultrasonography. DVT was associated with a history of DVT, cancer, previous immobilization, calf compression pain, calf circumference difference, and a few laboratory abnormalities, e.g., increased D-dimer. A multivariate regression model with stepwise backward selection identified the Wells score (odds ratio 35.46, 95%-confidence interval 4.71-519.92) as a significant predictor for DVT.
Conclusion:
DVT is present in a relevant proportion of patients with cerebral ischemia and PFO, which needs to be considered for the individual diagnostic workup. The Wells score seems suitable for guiding additional examinations, i.e., compression ultrasonography.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

